Neuromedin U receptors in GtoPdb v.2023.1

Neuromedin U receptors (provisional nomenclature as recommended by NC-IUPHAR [30]) are activated by the endogenous 25 amino acid peptide neuromedin U (neuromedin U-25, NmU-25), a peptide originally isolated from pig spinal cord [92]. In humans, NmU-25 appears to be the sole product of a precursor gene (NMU, P48645) showing a broad tissue distribution, but which is expressed at highest levels in the upper gastrointestinal tract, CNS, bone marrow and fetal liver. Much shorter versions of NmU are found in some species, but not in human, and are derived at least in some instances from the proteolytic cleavage of the longer NmU. Despite species differences in NmU structure, the C-terminal region (particularly the C-terminal pentapeptide) is highly conserved and contains biological activity. Neuromedin S (neuromedin S-33) has also been identified as an endogenous agonist [97]. NmS-33 is, as its name suggests, a 33 amino-acid product of a precursor protein derived from a single gene and contains an amidated C-terminal heptapeptide identical to NmU. NmS-33 appears to activate NMU receptors with equivalent potency to NmU-25.

[1]  K. Mori,et al.  Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability. , 2020, Bioorganic & Medicinal Chemistry Letters.

[2]  K. Mori,et al.  A chemically stable peptide agonist to neuromedin U receptor type 2. , 2020, Bioorganic & Medicinal Chemistry.

[3]  Peter Buneman,et al.  Why data citation isn't working, and what to do about it , 2020, Database J. Biol. Databases Curation.

[4]  M. Miyazato,et al.  Purification and identification of native forms of goldfish neuromedin U from brain and gut. , 2019, Biochemical and biophysical research communications.

[5]  N. Anastasio,et al.  Binge-Type Eating in Rats is Facilitated by Neuromedin U Receptor 2 in the Nucleus Accumbens and Ventral Tegmental Area , 2019, Nutrients.

[6]  Jonathan D. Hommel,et al.  Incubation of feeding behavior is regulated by neuromedin U receptor 2 in the paraventricular nucleus of the hypothalamus , 2018, Behavioural Brain Research.

[7]  Lei Gao,et al.  Identification of NMU as a potential gene conferring alectinib resistance in non-small cell lung cancer based on bioinformatics analyses. , 2018, Gene.

[8]  J. Hommel,et al.  Cocaine-Evoked Locomotor Activity Negatively Correlates With the Expression of Neuromedin U Receptor 2 in the Nucleus Accumbens , 2018, Front. Behav. Neurosci..

[9]  Na Ye,et al.  Small‐Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models , 2018, Pharmacology research & perspectives.

[10]  K. Nakao,et al.  Role of neuromedin U in accelerating of non-alcoholic steatohepatitis in mice , 2018, Peptides.

[11]  J. Noguchi,et al.  PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration , 2017, Peptides.

[12]  H. Hirabayashi,et al.  Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide. , 2017, Journal of medicinal chemistry.

[13]  K. Mori,et al.  Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability. , 2017, Journal of medicinal chemistry.

[14]  B. Patel,et al.  Neuromedin: An insight into its types, receptors and therapeutic opportunities , 2017, Pharmacological reports : PR.

[15]  T. Shinohara,et al.  A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects. , 2017, Bioorganic & medicinal chemistry.

[16]  E. Dahl,et al.  Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway , 2017, Oncotarget.

[17]  E. Egecioglu,et al.  Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol‐induced reward in rodents , 2016, Addiction biology.

[18]  H. Meltzer,et al.  Gamma-Aminobutyric Acidergic Projections From the Dorsal Raphe to the Nucleus Accumbens Are Regulated by Neuromedin U , 2016, Biological Psychiatry.

[19]  Y. Hayashi,et al.  Identification of a degrading enzyme in human serum that hydrolyzes a C‐terminal core sequence of neuromedin U , 2016, Biopolymers.

[20]  E. Jerlhag,et al.  The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice , 2016, PloS one.

[21]  K. Mori,et al.  Involvement of endogenous neuromedin U and neuromedin S in thermoregulation. , 2016, Biochemical and biophysical research communications.

[22]  A. Schier,et al.  A Zebrafish Genetic Screen Identifies Neuromedin U as a Regulator of Sleep/Wake States , 2016, Neuron.

[23]  Zhongyou Li,et al.  NMU signaling promotes endometrial cancer cell progression by modulating adhesion signaling , 2016, Oncotarget.

[24]  A. Waring,et al.  Small lipidated anti-obesity compounds derived from neuromedin U. , 2015, European journal of medicinal chemistry.

[25]  C. Luo,et al.  Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro , 2015, PloS one.

[26]  J. Jelsing,et al.  A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents , 2015, PloS one.

[27]  K. Mori,et al.  Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites. , 2015, ACS medicinal chemistry letters.

[28]  Ling Zhang,et al.  Design, synthesis and biological activity of flavonoid derivatives as selective agonists for neuromedin U 2 receptor. , 2014, Bioorganic & medicinal chemistry.

[29]  K. Mori,et al.  Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2. , 2014, Journal of medicinal chemistry.

[30]  L. O’Driscoll,et al.  Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors. , 2014, Cancer research.

[31]  Lixia Guo,et al.  p-Synephrine: a novel agonist for neuromedin U2 receptor. , 2014, Biological & pharmaceutical bulletin.

[32]  G. Telegdy,et al.  Neurotransmissions of antidepressant-like effects of neuromedin U-23 in mice , 2014, Behavioural Brain Research.

[33]  Jonathan D. Hommel,et al.  Neuromedin U receptor 2 knockdown in the paraventricular nucleus modifies behavioral responses to obesogenic high-fat food and leads to increased body weight , 2014, Neuroscience.

[34]  A. Peier,et al.  Development of a neuromedin U–human serum albumin conjugate as a long‐acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide , 2014, Journal of peptide science : an official publication of the European Peptide Society.

[35]  G. Telegdy,et al.  Anxiolytic action of neuromedin-U and neurotransmitters involved in mice , 2013, Regulatory Peptides.

[36]  W. Ahrens,et al.  Understanding the Links among neuromedin U Gene, beta2-adrenoceptor Gene and Bone Health: An Observational Study in European Children , 2013, PloS one.

[37]  I. Sakata,et al.  Negative Regulation of Neuromedin U mRNA Expression in the Rat Pars Tuberalis by Melatonin , 2013, PloS one.

[38]  A. Peier,et al.  PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes. , 2012, Bioorganic & medicinal chemistry.

[39]  F. Liu,et al.  Neuromedin S Increases L-type Ca2+ Channel Currents Through Giα-protein and Phospholipase C-dependent Novel Protein Kinase C Delta Pathway in Adult Rat Ventricular Myocytes , 2012, Cellular Physiology and Biochemistry.

[40]  Yuan Zhang,et al.  Neuromedin U Type 1 Receptor Stimulation of A-type K+ Current Requires the βγ Subunits of Go Protein, Protein Kinase A, and Extracellular Signal-regulated Kinase 1/2 (ERK1/2) in Sensory Neurons* , 2012, The Journal of Biological Chemistry.

[41]  R. Weissleder,et al.  The neuropeptide neuromedin U promotes autoantibody-mediated arthritis , 2012, Arthritis Research & Therapy.

[42]  S. Purcell,et al.  Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome-wide association study of comorbid alcoholism and bipolar disorder , 2011, Psychiatric genetics.

[43]  P. Pilowsky,et al.  Intrathecal neuromedin U induces biphasic effects on sympathetic vasomotor tone, increases respiratory drive and attenuates sympathetic reflexes in rat , 2011, British journal of pharmacology.

[44]  A. Peier,et al.  Effects of peripherally administered neuromedin U on energy and glucose homeostasis. , 2011, Endocrinology.

[45]  Joanna L. Sharman,et al.  IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data , 2010, Nucleic Acids Res..

[46]  Juan Su,et al.  The regulatory mechanism of neuromedin S on luteinizing hormone in pigs. , 2010, Animal reproduction science.

[47]  K. Mori,et al.  Comparison of feeding suppression by the anorexigenic hormones neuromedin U and neuromedin S in rats. , 2010, The Journal of endocrinology.

[48]  M. Fujimiya,et al.  Centrally administered neuromedin S inhibits feeding behavior and gastroduodenal motility in mice. , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[49]  N. Andersson,et al.  Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice. , 2009, American journal of physiology. Endocrinology and metabolism.

[50]  A. Peier,et al.  The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2). , 2009, Endocrinology.

[51]  S. Trivedi,et al.  Discovery and Pharmacological Characterization of a Small-Molecule Antagonist at Neuromedin U Receptor NMUR2 , 2009, Journal of Pharmacology and Experimental Therapeutics.

[52]  D. Bechtold,et al.  Appetite-modifying actions of pro-neuromedin U-derived peptides , 2009, American journal of physiology. Endocrinology and metabolism.

[53]  J. Hoheisel,et al.  Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway. , 2009, Cancer letters.

[54]  M. Sassek,et al.  Does Somatostatin Confer Insulinostatic Effects of Neuromedin U in the Rat Pancreas? , 2009, Pancreas.

[55]  K. Nagai,et al.  Autonomic and cardiovascular effects of central neuromedin U in rats , 2009, Physiology & Behavior.

[56]  A. Davenport,et al.  Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system. , 2008, Cardiovascular research.

[57]  K. Mori,et al.  Involvement of neuromedin S in the oxytocin release response to suckling stimulus. , 2008, Biochemical and biophysical research communications.

[58]  C. Binkert,et al.  Distribution of neuromedin U binding sites in the rat CNS revealed by in vitro receptor autoradiography , 2008, Neuropeptides.

[59]  G. Nussdorfer,et al.  Neuromedin-U stimulates enucleation-induced adrenocortical regeneration in the rat. , 2008, International journal of molecular medicine.

[60]  A. Wise,et al.  Paradoxical Behavior of Neuromedin U in Isolated Smooth Muscle Cells and Intact Tissue , 2008, Journal of Pharmacology and Experimental Therapeutics.

[61]  H. Su,et al.  Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay , 2008, Acta Pharmacologica Sinica.

[62]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.

[63]  A. Ziółkowska,et al.  Effects of neuromedin-U on immature rat adrenocortical cells: in vitro and in vivo studies. , 2008, International journal of molecular medicine.

[64]  K. Mori,et al.  Identification and functional analysis of a novel ligand for G protein-coupled receptor, Neuromedin S , 2008, Regulatory Peptides.

[65]  S. Shioda,et al.  Isolation and Characterisation of Four cDNAs Encoding Neuromedin U (NMU) From the Brain and Gut of Goldfish, and the Inhibitory Effect of a Deduced NMU on Food Intake and Locomotor Activity , 2007, Journal of neuroendocrinology.

[66]  K. Mori,et al.  Neuromedin S: discovery and functions. , 2008, Results and problems in cell differentiation.

[67]  A. Ziółkowska,et al.  Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via the NMU receptor 2 isoform. , 2008, International journal of molecular medicine.

[68]  G. Telegdy,et al.  Endocrine and behavioral effects of neuromedin S , 2007, Hormones and Behavior.

[69]  C. Luo,et al.  Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs. , 2007, American journal of physiology. Endocrinology and metabolism.

[70]  Takahiro Matsumoto,et al.  Central control of bone remodeling by neuromedin U , 2007, Nature Medicine.

[71]  D. Theodorescu,et al.  RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation. , 2007, Urologic oncology.

[72]  A. Murphy,et al.  Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses , 2007, PAIN.

[73]  A. Ziółkowska,et al.  Expression of neuromedins S and U and their receptors in the hypothalamus and endocrine glands of the rat. , 2007, International journal of molecular medicine.

[74]  K. Sugahara,et al.  Central administration of neuromedin U suppresses food intake in chicks , 2007, Neuroscience Letters.

[75]  Valérie Capra,et al.  The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State , 2007, Molecular Pharmacology.

[76]  G. Sanger,et al.  Neuromedin U can exert colon‐specific, enteric nerve‐mediated prokinetic activity, via a pathway involving NMU1 receptor activation , 2007, British journal of pharmacology.

[77]  H. Frierson,et al.  Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia , 2007, Oncogene.

[78]  M. Tena-Sempere,et al.  Neuromedin s as novel putative regulator of luteinizing hormone secretion. , 2007, Endocrinology.

[79]  K. Murao,et al.  Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem , 2001, Endocrine.

[80]  Tatiana Foroud,et al.  Pooled association genome scanning for alcohol dependence using 104,268 SNPs: Validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[81]  T. Hansen,et al.  Association between neuromedin U gene variants and overweight and obesity. , 2006, The Journal of clinical endocrinology and metabolism.

[82]  L. Malendowicz,et al.  Neuromedin U receptor 1 expression in the rat endocrine pancreas and evidence suggesting neuromedin U suppressive effect on insulin secretion from isolated rat pancreatic islets. , 2006, International journal of molecular medicine.

[83]  J. Hohmann,et al.  Neuromedin U Receptor 2-Deficient Mice Display Differential Responses in Sensory Perception, Stress, and Feeding , 2006, Molecular and Cellular Biology.

[84]  Yusuke Nakamura,et al.  The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer. , 2006, Cancer research.

[85]  N. Shankley,et al.  Neuromedin U stimulates contraction of human long saphenous vein and gastrointestinal smooth muscle in vitro , 2006, Regulatory Peptides.

[86]  K. Mori,et al.  Structural and functional analogs of the novel mammalian neuropeptide, neuromedin S (NmS), in the dermal venoms of Eurasian bombinid toads. , 2006, Biochemical and biophysical research communications.

[87]  Takahiro Sato,et al.  Regulation of gonadotropin secretion and puberty onset by neuromedin U , 2006, FEBS letters.

[88]  S. Bloom,et al.  Neuromedin U partially mediates leptin-induced hypothalamo-pituitary adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat. , 2006, Endocrinology.

[89]  A. Yoshimura,et al.  The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[90]  N. Shankley,et al.  Species‐dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice , 2006, British journal of pharmacology.

[91]  A. Yoshimura,et al.  The neuropeptide neuromedin U promotes IL-6 production from macrophages and endotoxin shock. , 2006, Biochemical and biophysical research communications.

[92]  K. Mori,et al.  Neuromedin s is a novel anorexigenic hormone. , 2005, Endocrinology.

[93]  S. Bloom,et al.  Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin. , 2005, American journal of physiology. Endocrinology and metabolism.

[94]  A. Yoshimura,et al.  The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells , 2005, The Journal of experimental medicine.

[95]  R. Lai,et al.  Identification and molecular cloning of a novel neuromedin U analog from the skin secretions of toad Bombina maxima , 2005, Regulatory Peptides.

[96]  Richard R. Neubig,et al.  International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List , 2005, Pharmacological Reviews.

[97]  T. Kowalski,et al.  Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. , 2005, The Journal of endocrinology.

[98]  R. Zeillinger,et al.  Identification of L1CAM, Jagged2 and Neuromedin U as ovarian cancer-associated antigens. , 2005, Oncology reports.

[99]  K. Kangawa,et al.  Endogenous neuromedin U has anorectic effects in the Japanese quail. , 2005, General and comparative endocrinology.

[100]  P. Morgan,et al.  Neuromedin‐U is regulated by the circadian clock in the SCN of the mouse , 2005, The European journal of neuroscience.

[101]  K. Mori,et al.  Identification of neuromedin S and its possible role in the mammalian circadian oscillator system , 2005, The EMBO journal.

[102]  H. Sarau,et al.  Neuromedin Elicits Cytokine Release in Murine Th2-Type T Cell Clone D10.G4.1 , 2004, The Journal of Immunology.

[103]  P. Szekeres,et al.  Signaling and Ligand Binding by Recombinant Neuromedin U Receptors: Evidence for Dual Coupling to Gαq/11 and Gαi and an Irreversible Ligand-Receptor Interaction , 2004, Molecular Pharmacology.

[104]  K. Kangawa,et al.  Neuromedin U is involved in nociceptive reflexes and adaptation to environmental stimuli in mice. , 2004, Biochemical and biophysical research communications.

[105]  N. Martin,et al.  Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight. , 2004, Biochemical and biophysical research communications.

[106]  S. Bhattacharyya,et al.  Studies of the neuromedin U-2 receptor gene in human obesity: evidence for the existence of two ancestral forms of the receptor. , 2004, The Journal of endocrinology.

[107]  M. Ikawa,et al.  Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway , 2004, Nature Medicine.

[108]  A. Gewirtz,et al.  Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias. , 2004, Blood.

[109]  H. Sarau,et al.  Radioligand Binding and Functional Characterization of Recombinant Human NmU1 and NmU2 Receptors Stably Expressed in Clonal Human Embryonic Kidney-293 Cells , 2004, Pharmacology.

[110]  J. Hagan,et al.  Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats , 2004, Psychopharmacology.

[111]  P. Szekeres,et al.  Neuromedin U and Its Receptors: Structure, Function, and Physiological Roles , 2004, Pharmacological Reviews.

[112]  K. Kangawa,et al.  The gut-brain peptide neuromedin U is involved in the mammalian circadian oscillator system. , 2004, Biochemical and biophysical research communications.

[113]  J. Polak,et al.  Neuromedin U-like immunoreactivity in the thyroid gland of the rat , 1990, Cell and Tissue Research.

[114]  P. Barrett,et al.  Neuromedin U and Neuromedin U receptor‐2 expression in the mouse and rat hypothalamus: effects of nutritional status , 2003, Journal of neurochemistry.

[115]  Y. Kanai,et al.  Central actions of neuromedin U via corticotropin-releasing hormone. , 2003, Biochemical and biophysical research communications.

[116]  M. Furuta,et al.  Effects of neuromedin U on the pulsatile LH secretion in ovariectomized rats in association with feeding conditions. , 2003, Biochemical and biophysical research communications.

[117]  A. Dray,et al.  Pro-nociceptive effects of neuromedin u in rat , 2003, Neuroscience.

[118]  Xiao Hong Yu,et al.  A pro-nociceptive role of neuromedin U in adult mice , 2003, Pain.

[119]  K. Toshinai,et al.  Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[120]  F. Sato,et al.  Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. , 2002, Cancer cell.

[121]  M. Nakazato,et al.  Centrally administered neuromedin U activates neurosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat. , 2002, Endocrinology.

[122]  C. Lawrence,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society doi: 10.1210/en.2002-220121 Evaluation of Neuromedin U Actions in Energy Homeostasis and Pituitary Function , 2022 .

[123]  F. Monsma,et al.  Cloning and characterization of murine neuromedin U receptors , 2002, Peptides.

[124]  J. Hieble,et al.  Characterization of neuromedin U effects in canine smooth muscle. , 2002, Journal of Pharmacology and Experimental Therapeutics.

[125]  M. Nakazato,et al.  Cardiovascular actions of central neuromedin U in conscious rats , 2002, Regulatory Peptides.

[126]  S. Bloom,et al.  Hypothalamic actions of neuromedin U. , 2002, Endocrinology.

[127]  T. Suda,et al.  A role for neuromedin U in stress response. , 2001, Biochemical and biophysical research communications.

[128]  R. Todd,et al.  Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis , 2001, Oncogene.

[129]  L. V. D. van der Ploeg,et al.  Distribution of neuromedin U receptor subtype 2 mRNA in the rat brain. , 2001, Brain research. Gene expression patterns.

[130]  F. Monsma,et al.  Identification of a Novel Neuromedin U Receptor Subtype Expressed in the Central Nervous System* , 2000, The Journal of Biological Chemistry.

[131]  B. Borowsky,et al.  Identification and Characterization of Two Neuromedin U Receptors Differentially Expressed in Peripheral Tissues and the Central Nervous System* , 2000, The Journal of Biological Chemistry.

[132]  M. Nakazato,et al.  Central effects of neuromedin U in the regulation of energy homeostasis. , 2000, Biochemical and biophysical research communications.

[133]  F. Monsma,et al.  Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U. , 2000, Molecular pharmacology.

[134]  M. Nakazato,et al.  Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). , 2000, Biochemical and biophysical research communications.

[135]  H. Matsui,et al.  Identification and Functional Characterization of a Novel Subtype of Neuromedin U Receptor* , 2000, The Journal of Biological Chemistry.

[136]  O. Nishimura,et al.  Identification of Neuromedin U as the Cognate Ligand of the Orphan G Protein-coupled Receptor FM-3* , 2000, The Journal of Biological Chemistry.

[137]  J. Chambers,et al.  Neuromedin U Is a Potent Agonist at the Orphan G Protein-coupled Receptor FM3* , 2000, The Journal of Biological Chemistry.

[138]  Christopher P. Austin,et al.  Identification of receptors for neuromedin U and its role in feeding , 2000, Nature.

[139]  S. Bloom,et al.  Isolation, Structural Characterization, and Bioactivity of a Novel Neuromedin U Analog from the Defensive Skin Secretion of the Australasian Tree Frog, Litoria caerulea * 210 , 2000, The Journal of Biological Chemistry.

[140]  D. Smith,et al.  Effect of steroids and the estrous cycle on uterine neuromedin U receptor expression , 1999, Peptides.

[141]  A. Howard,et al.  Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors. , 1998, Genomics.

[142]  S. Bloom,et al.  Cloning and characterization of the cDNA encoding the human neuromedin U (NmU) precursor: NmU expression in the human gastrointestinal tract. , 1995, Journal of molecular endocrinology.

[143]  J. Warchoł,et al.  Effects of neuromedin U-8 on the secretory activity of the rat adrenal cortex: evidence for an indirect action requiring the presence of the zona medullaris , 1994, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[144]  G. Mazzocchi,et al.  Effects of neuromedin U-8 on the rat pituitary-adrenocortical axis. , 1993, In Vivo.

[145]  D. Smith,et al.  Characterization of the rat uterine neuromedin U receptor. , 1993, Endocrinology.

[146]  A. Aitken,et al.  The purification and sequence analysis of an avian neuromedin U , 1992, Regulatory Peptides.

[147]  H. Masui,et al.  Agonistic and antagonistic activities of neuromedin U-8 analogs substituted with glycine or D-amino acid on contractile activity of chicken crop smooth muscle preparations. , 1991, Chemical and pharmaceutical bulletin.

[148]  T. Hashimoto,et al.  Structure-activity relationships of rat neuromedin U for smooth muscle contraction. , 1991, Chemical & pharmaceutical bulletin.

[149]  P. Abel,et al.  Primary structure and pharmacological activity of a nonapeptide related to neuromedin U isolated from chicken intestine , 1991, Peptides.

[150]  L. Thim,et al.  Rabbit neuromedin U-25: lack of conservation of a posttranslational processing site , 1991, Regulatory Peptides.

[151]  P. Abel,et al.  Isolation, structural characterization and pharmacological activity of dog neuromedin U , 1991, Peptides.

[152]  J. Domin,et al.  The motor effect of neuromedin U on rat stomach in vitro. , 1991, European journal of pharmacology.

[153]  A. Giraud,et al.  Isolation and microsequence analysis of a novel form of neuromedin U from guinea pig small intestine , 1990, Peptides.

[154]  C. Maggi,et al.  Motor response of the human isolated small intestine and urinary bladder to porcine neuromedin U‐8 , 1990, British journal of pharmacology.

[155]  S. Gardiner,et al.  Regional hemodynamic effects of neuromedin U in conscious rats. , 1990, The American journal of physiology.

[156]  Y. Yiangou,et al.  The distribution, purification, and pharmacological action of an amphibian neuromedin U. , 1989, The Journal of biological chemistry.

[157]  J. Polak,et al.  The Distribution and Biological Effects of Neuromedins B and U , 1988, Annals of the New York Academy of Sciences.

[158]  N. Minamino,et al.  Isolation and structural determination of rat neuromedin U. , 1988, Biochemical and biophysical research communications.

[159]  L. Thim,et al.  Primary Structure of Neuromedin U from the Rat , 1988, Journal of neurochemistry.

[160]  S. Sumi,et al.  Effect of synthetic neuromedin U-8 and U-25, novel peptides identified in porcine spinal cord, on splanchnic circulation in dogs. , 1987, Life sciences.

[161]  M. Ghatei,et al.  Characterization of neuromedin U like immunoreactivity in rat, porcine, guinea-pig and human tissue extracts using a specific radioimmunoassay. , 1986, Biochemical and biophysical research communications.

[162]  N. Minamino,et al.  Neuromedin U-8 and U-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. , 1985, Biochemical and biophysical research communications.